Posts Tagged: CTC

LiquidBiopsy_Conferences_700x233

This year’s top liquid biopsy conferences around the world

One of the most-discussed technologies of 2015 was liquid biopsy-based translational research and its future importance in precision medicine. In 2016, even more dedicated conferences will focus on liquid biopsy, with leaders in industry and academia discussing the potential of this essential tool of personalized healthcare going forward. As I have been following this topic very closely over the last year, I… Read article →


Blood_Liquid-Biopsy_700x233

The Future’s So Bright: Liquid Biopsy in 2016

Basic scientists, clinicians and market analysts are all optimistic about the prospects for liquid biopsy in 2016. Several reports have determined that liquid biopsy is a growing market segment for cancer diagnosis and management (1–2), expected to reach $20 billion in the next five years (1). Biotech startups and major companies alike have jumped in… Read article →


CTCs+miRNAs_700x233

How might regulatory RNAs impact CTC analysis?

Liquid biopsy, the concept of discovering or monitoring disease by a simple blood test or other biofluid, overcomes many of the challenges of a traditional tissue biopsy. It’s less invasive, and simplifies collection of multiple samples over the course of disease progression and treatment. It’s not an overstatement to say that liquid biopsy is revolutionizing… Read article →


SingleCell_miRNA_MagnifyingGlass_700x233

Small RNAs in small samples – what’s the value in single-cell microRNA analysis?

microRNA profiling has revolutionized our understanding of gene regulation. Technological advances are now enabling us to drill down further to the fine details – small RNA sequencing to identify undiscovered microRNAs, for example, preamplification to improve qPCR results from small samples and kits to reveal the small RNA contents of exosomes. Single-cell analysis is an… Read article →


Blood_Liquid-Biopsy_700x233

CTCs and their central role in metastatic cascade, tumor dissemination and progression

Circulating tumor cells (CTCs) can be detected from the peripheral blood of cancer patients, and are viewed as a unique “liquid biopsy” for cancer prognosis and diagnosis (1). Unlike other cancer biomarkers, CTCs represent a sampling of the patient’s primary tumor. Furthermore, CTCs play a crucial role in tumor dissemination and progression, and are widely… Read article →